The differential loss of [3H]pirenzepine vs [3H](-)Quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor

William R. Roeske, J. Craig Venter

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

[3H]Pirenzepine ([3H]PZ) and [3H](-)Quinuclidinylbenzilate ([3H](-)QNB) specific binding to soluble rat brain muscarinic cholinergic receptors was assessed as a function of time subsequent to receptor solubilization. The soluble brain muscarinic receptor is stable at 4°C when assayed by [3H](-)QNB binding (t 1 2 = 80 hrs). In contrast the pirenzepine state of the receptor decays rapidly (t 1 2 = 3.0 hrs). Prior occupation of the receptor with [3H](-)QNB or [3H]PZ increases the receptor stability by two to five fold (t 1 2 QNB >1,000 hrs; t 1 2 PZ = 6.5 hrs). These data indicate that pirenzepine binds to an allosteric state of the muscarinic receptor and that caution should be employed in the assignment of receptor subtypes based solely upon the binding of ligands which recognize unique conformational states.

Original languageEnglish (US)
Pages (from-to)950-957
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume118
Issue number3
DOIs
StatePublished - Feb 14 1984

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'The differential loss of [<sup>3</sup>H]pirenzepine vs [<sup>3</sup>H](-)Quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor'. Together they form a unique fingerprint.

  • Cite this